Enzo Fernández to Manchester City: £125m deal agreed

Enzo Fernández is set to join Manchester City from Chelsea after the two clubs reached an agreement for a fee worth over £125m, according to Fabrizio Romano. The Argentine midfielder has been granted permission to undergo a medical in Manchester to complete the move before the transfer deadline.

The deal follows a long period of negotiation between the Premier League rivals. Chelsea have now approved the sale of the 25-year-old, who reportedly only wanted a move to the Etihad Stadium. The package matches the British transfer record, according to David Ornstein. Final details are currently being sorted between the clubs to finalise the paperwork.

While the primary fee is cited at £125m, figures vary slightly across reports. The total cost is estimated between £120m and £130m, according to Florian Plettenberg. Fernández was described as a “dream target” for City, with discussions regarding the move dating back to May.

The deal

Fee: £125m (Ben Jacobs)
Stage: Medical booked (Fabrizio Romano)
Status: Agreement in principle (David Ornstein)

The departure of Fernández comes during a busy deadline day for Chelsea. The club has already confirmed the signing of Honest Ahanor from Atalanta for £40m, according to a club statement. Additionally, Marc Guiu has left the club on a permanent transfer, while Shim Mheuka has joined Celtic on a season-long loan deal.

SPORF FACTFILE

Enzo Fernández

Age	25
Position	Central Midfield
Nationality	Argentina
Current club	Chelsea

What happens next

Enzo Fernández will travel to Manchester this evening to undergo his medical examinations. Once the medical is passed, the clubs will race to submit the necessary documents before the transfer window closes. An official announcement from Manchester City is expected late tonight or early tomorrow morning.

Follow all the latest in our Chelsea transfer news hub.

Every completed deal of the window, updated as clubs confirm them: Confirmed transfers 2026: every Premier League done deal — LIVE.